In Vitro Diagnostic (IVD) Instruments Producers and IVD Instruments Market Trend

In vitro diagnostic (IVD) instruments are instruments that obtain test conclusions through quantitative and qualitative analysis of compounds or chemical reactions produced when test reagents react biochemically with substances in the human body, and they play an important role in disease prevention, diagnosis, disease monitoring, and prediction of genetic diseases. In vitro diagnostic equipment can be divided into several categories, such as biochemical analysis equipment, immunoassay equipment, molecular diagnostic equipment and POCT equipment.

The global in vitro diagnostic instruments market size was USD 13.7 billion in 2017, growing to USD 22.4 billion in 2022, with a CAGR of 10.3% from 2017 to 2022. The global in vitro diagnostic instruments market size is expected to reach USD 42 billion in 2027, with a CAGR of 13.4% from 2022 to 2027.

Figure 2017-2027 Global IVD Instruments Market Size (Billion USD) and CAGR

Roche, Siemens, Abbott, Danaher, Thermo Fisher, Becton Dickinson (BD), Virax Biolabs Group Ltd, Sysmex, Illumina, Ortho Clinical Diagnostics are global leading IVD companies. There are also a number of medium and small players including Bio Rad, Qiagen, GrifolsShengzhen Mindray, Autobio Diagnostics, Shanghai Kehua, Daan Gene, Beijing Leadman, Livzon Pharmaceutical, Shenzhen New Industries, Guangzhou Wondfo, SD Biosensor, ACON Laboratories, Adaptive Biotechnologies Corporation, Immuco, OraSure Technologies, Quidel Corporation, and Bio-Merieux.